NKTR

HEALTHY

NEKTAR THERAPEUTICS

CIK: 0000906709

Sell (70% confidence)

Last activity: Feb 18, 2026

Financial Metrics

As of Dec 31, 2025 (10-K)

Revenue $307.71M

Net Income -$164.08M

Current Ratio 5.89

Insider	Sells	Net Value	Holdings
Zalevsky Jonathan Chief R&D Officer	3	-$214K	21,174 shares $1.55M
ROBIN HOWARD W President & CEO	2	-$151K	75,489 shares $5.51M
Wilson Mark Andrew Chief Legal Officer	1	-$34K	21,585 shares $1.17M

SELL ROBIN HOWARD W (President & CEO)

423 shares @ $73.00

$31K

Feb 18, 2026

Conviction: | View SEC Filing →

SELL Zalevsky Jonathan (Chief R&D Officer)

180 shares @ $73.00

$13K

Feb 18, 2026

Conviction: | View SEC Filing →

SELL Zalevsky Jonathan (Chief R&D Officer)

3,867 shares @ $35.67

$138K

Jan 20, 2026

Conviction: | View SEC Filing →

SELL ROBIN HOWARD W (President & CEO)

2,207 shares @ $54.28

$120K

Nov 25, 2025

Conviction: | View SEC Filing →

SELL Zalevsky Jonathan (Chief R&D Officer)

1,157 shares @ $54.28

$63K

Nov 25, 2025

Conviction: | View SEC Filing →

SELL Wilson Mark Andrew (Chief Legal Officer)

630 shares @ $54.28

$34K

Nov 25, 2025

Conviction: | View SEC Filing →

• This is AI-generated analysis for educational purposes only, not financial advice.

• Insider trading data is derived from SEC Form 4 filings and may contain errors.

• Always conduct your own research and consult qualified financial advisors before making investment decisions.